Family Caregiver of Patient With Alzheimer Disease Clinical Trial
Official title:
Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder
| Verified date | November 2023 |
| Source | Centre Hospitalier Universitaire de Nice |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study aims to assess the effectiveness of serious EUREKOI gambling on the anxiety of family caregivers of patients with newly diagnosed Alzheimer's disease.
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | September 6, 2022 |
| Est. primary completion date | September 6, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Men or women over 18 years old; - Primary caregiver of a patient with a mild-stage major neurocognitive disorder newly diagnosed according to the DSM 5 criteria; - Signature of informed consent. Exclusion Criteria: - Subject not speaking French, not reading French - Subject with visual impairment - Subject under tutorship or curatorship. |
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Nice | Nice |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Nice |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Efficacity of the serious game Eurekoi on anxiety of familial caregiver of patient with Alzheimer Disease | Auto-evaluation of anxiety using Spielberger inventory (score between 20 and 80 ; the higher the score, the greater the anxiety) | 3 months | |
| Secondary | Change of knowledge of familial caregiver about cognitive troubles | Multiple choice questionary | 3 months | |
| Secondary | Evaluate satisfaction of the familial caregivers about the session with the game EUREKOI | questionary of satisfaction | 3 months |